Research Project
Project Title: |
Phase 2, double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of ravulizumab in adult participants with proliferative lupus nephritis (LN) or immunoglobulin A nephropathy (IgAN) |
Project Type: |
Clinical Trial, Enrolment ongoing |
Disease group(s): |
Immune glomerulopathies |
Project Summary: |
This is a phase 2, double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of ravulizumab in adult participants with proliferative lupus nephritis (LN) or immunoglobulin A nephropathy (IgAN). |
Lead principal investigator(s): |
Gaetano La Manna, Bologna |
Co-investigator(s): |
Olga Baraldi, Bologna |
Project Period: |
09/2021 - 09/2050 |
Sponsors: |
Industry |
« Back to research page